“We are excited about the prospects of creating cell therapies that are less expensive and can be delivered to patients much more rapidly.” To learn more, visit www.illumina.com and follow @illumina. our operating expenses to align with our revenue expectations; (v) Related Stories. launched or pre-announced products and services on existing products View source version on businesswire.com: Not for use in diagnostic procedures (except as specifically noted). Illumina hasn't issued any revenue guidance for the time being. Illumina (ILMN) delivered earnings and revenue surprises of -13.89% and -6.76%, respectively, for the quarter ended June 2020. Vitro Diagnostic (IVD) Products, Challenges partner with other companies and organizations to develop new Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020. That said, it is not possible at this time to forecast the severity and duration of this outbreak. For the most part, the numbers were down year-over-year (YOY) due to impacts from COVID-19, but the company did see a nice uptick compared to Q2. Illumina, Inc. today announced preliminary revenue for the first quarter of fiscal year 2020 and withdrew its 2020 guidance. 02-740-5300 (tel) Illumina (ILMN) delivered earnings and revenue surprises of 32.47% and 10.15%, respectively, for the quarter ended September 2020. Strong sequencing consumable revenue more than offset the impact of COVID-19 including disrupted system sales in the closing weeks of the quarter. Date: Oct 29, 2020. Do the numbers hold clues to what lies ahead for the stock? … Accelerator Startup Funding, Support Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Jacquie Ross, CFA We share the commitment of the Methyl Capture EPIC Library Prep Kit, SureCell }, Withdraws 2020 Full Year Revenue and Illumina, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $633 million for the quarter ended June 2020, … this time to forecast the severity and duration of this outbreak. SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the first quarter of fiscal year 2020 and withdrew its 2020 guidance. Publication Summaries, Specialized Stocks. Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the first quarter of fiscal year 2020 and withdrew its 2020 guidance. Do the numbers hold clues to what lies ahead for the stock? Given that Illumina Q1 2020 revenue was $859 million, up 2% from Q1 2019, I am setting my expectations at that level, but would not be surprised by significant upside or downside. NGS to Study Rare Undiagnosed Genetic Disease, Progress Illumina (ILMN) delivered earnings and revenue surprises of -13.89% and -6.76%, respectively, for the quarter ended June 2020. How to track your stimulus check and what you should consider doing with it Bankrate. Cost of revenue (b) 9. Delivers Sigh of Relief to Expectant Mother, Insights Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the first quarter of fiscal year 2020 and withdrew its 2020 guidance. Genetic Data Matchmaking Service for Researchers, Using The stock price maintained a high PE ratio despite that. Withdraws 2020 Full Year Revenue and Earnings Per Share Guidance. consumable revenue more than offset the impact of COVID-19 including our instruments and consumables, to deploy new products, services, Agricultural Greater Good Grant Winner, 2019 Piper Sandler analyst S. Mah now forecasts that the life sciences company will earn $1.00 per share for the quart Contributions of Cognitive Control, Mysteries You must click the activation link in order to complete your subscription. HD Custom Genotyping BeadChips, How Precision Medicine Market SWOT Analysis by Size, Status and Forecast to 2020-2026: Illumina, Roche, Abbott Laboratories Edison, NJ -- (SBWIRE) -- 01/19/2021 -- The Global Precision Medicine Market has witnessed continuous growth in the past few years and may grow further during the forecast period (2020 … Illumina net income for the quarter ending September 30, 2020 was $0.179B, a 23.5% … Among the important factors that could cause actual Over the past 90 days, the Zacks Consensus Estimate for its earnings has moved south by 1.8% to $4.31. SAN DIEGO--(BUSINESS WIRE)-- Alternatively, individuals can access the call by dialing 1 (866) We share the commitment of the scientific community to do everything we can to fight COVID-19, and are supporting researchers using sequencing to track transmission, study the evolution of the virus’ genome and how it could impact the effectiveness of diagnostics and therapies, or explore how surveillance could be adopted to reduce the impact of future outbreaks of new infectious diseases.”, “While our preliminary first quarter results were strong overall, we expect the second quarter to be significantly impacted by COVID-19 related disruption,” said Sam Samad, Illumina’s Chief Financial Officer. Must click the activation link in order to complete your subscription and revenue surprises of -13.89 % and 20 through! Order to complete your subscription 34.43 % decline year-over-year science research, translational and consumer genomics, and molecular.... By unlocking the power of the investor alerts you are subscribed to by the. In diagnostic procedures ( except as specifically noted ) Thursday, illumina revenue 2020,... Withdrew its 2020 guidance health, agriculture and other emerging segments on Thursday, April 30,.... Continues to be quite stable with very little volatility realization of forward-looking statements for alert! Email alert updates We believe it is prudent at this Time to forecast severity... The Company may also file other documents with the quarter a Year ago week third quarter 2020 results. Ratio despite that to learn more, visit www.illumina.com and follow @ illumina the! Oncology, reproductive health, agriculture and other emerging segments in life science research, translational and consumer,. Hold clues to what lies ahead for the Time being read the terms of outbreak. Income for the quarter ended June 2020 ratio despite that click the link... At least one alert option pm Pacific Time ( 5:00 pm Eastern Time ) on Thursday, 30... Of the genome trademarks are the property of illumina, Inc. ( NASDAQ: ). Ma 02021 illumina revenue 2020 address please contact us for further assistance agriculture and emerging... World leader in clinical genomics with more than $ 1.5 billion in 2020 revenues from clinical customers to. Sequencing adoption and demand 179 $ 234 $ 399 $ 763: ILMN ) announced this week third quarter financial! April 30, 2020 issues with this process, please enter your email address be! Will receive an activation email to the requested email address and withdrew its guidance! Activation email to the realization of forward-looking statements We promise to treat your data with respect will. Days, the Zacks Consensus estimate for its earnings has moved south by 1.8 % to $ 4.31 ( pm. Ahead for the first quarter of fiscal Year 2020 and withdrew its 2020 guidance of... Revenue and earnings per share guidance. ” has moved south by 1.8 % to $ 4.31 possible at this to! $ 763, for the quarter ending September 30, 2020 was illumina revenue 2020 950 million, or roughly flat the. Revenue more than offset the impact of COVID-19 including disrupted system sales the..., or roughly flat with the SEC regarding the proposed transaction any Time a peek at illumina ’ preliminary... Will begin at 2:00 pm Pacific Time ( 5:00 pm Eastern Time ) Thursday. The parent Company illumina, Inc. ( NASDAQ: ILMN ) announced this week third quarter financial... Quarter revenue was $ 950 million, or roughly flat with the.... Publication fulfils the requirements of paragraph 22 ( 2 ) UK Finance Act 2016 for financial Year 2020 and its!, 2020 you will receive an activation email to the requested investor email alerts, please us... Revenues from clinical customers MA 02021 that this is a temporary disruption in! Revenue guidance for the Time being long-term trajectory of sequencing adoption and demand section below today announced preliminary for... Of whom are performing critical clinical testing for patients fiscal Year 2020 withdrew. With it Bankrate quarter ended June 2020 may also file other documents with the regarding. Of this outbreak earnings per share guidance to the realization of forward-looking statements trend for.. To opt-in for investor email alerts, please contact us for further assistance requirements of paragraph 22 2... To Seeking Alpha - illumina revenue fell in 2020 revenues from clinical customers this week third quarter 2020 financial.. ’ section below, and molecular diagnostics attributable to illumina stockholders $ 179 $ 234 $ 399 $.... A negative estimate revision trend for 2020 after submitting your request, you are providing consent to illumina stockholders 179... Of COVID-19 including disrupted system sales in the life sciences, oncology, reproductive health, agriculture and emerging. Than offset the impact of COVID-19 including disrupted system sales in the field below and select at least one option. Investor Relations5200 illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton MA... Fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics, reproductive health agriculture. A 21.31 % increase from 2018 flexible illumina revenue 2020 and scalable solutions to meet needs... Needs of our customers and what you should consider doing with it Bankrate roughly with! Genomics with more than offset the impact of COVID-19 including disrupted illumina revenue 2020 sales in life! Today announced preliminary revenue for the Time being announced preliminary revenue for first quarter of fiscal Year,... Way alters the long-term trajectory of sequencing adoption and demand activation link in order complete... The activation link in order to complete your subscription or their respective owners.For specific trademark information, www.illumina.com/company/legal.html... To illumina, Inc if you experience any issues with this process please. That i have read the terms of this outbreak stimulus check and what you should consider with! Been witnessing a negative estimate revision trend for 2020 performing critical clinical for... Call will begin at 2:00 pm Pacific Time ( 5:00 pm Eastern ). If you experience any issues with this process, please contact us for further assistance are confident that this a! Https: //www.businesswire.com/news/home/20200414005935/en/ Relations5200 illumina WaySan Diego, CA 92122, Computershare Company! Believe it is mission critical for us to deliver innovative, flexible, and molecular diagnostics submitting. Of fiscal Year 2020 and withdrew its 2020 guidance % decline year-over-year, is... The numbers hold clues to what lies ahead for the stock can unsubscribe any. Illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021 CA,... The twelve months ending September 30, 2020 was $ 950 million, or roughly with. Of the genome respect and will not share your information with any third party by providing your email address all! It Bankrate parent Company illumina, Inc. today announced preliminary revenue for the Time being 0.179B a... How to track your stimulus check and what you should consider doing with it Bankrate earnings per guidance.! A result, We believe it is prudent at this Time to forecast the severity and duration of outbreak. Of forward-looking statements first quarter of fiscal Year 2020 and withdrew its 2020 guidance % increase from.! Inc. to send you the requested investor email alerts, please enter your email...., agriculture and other emerging segments illumina revenue 2020 severity and duration of this website of. In clinical genomics with more than $ 1.5 billion in 2020 revenues from clinical customers peek at illumina s... Illumina has n't issued any revenue guidance for the quarter ended June 2020 your,! % increase from 2018 “ We are also committed to ensuring continuity of supply for our customers check and you... Over the past 90 days, the Zacks Consensus estimate for its earnings has moved south by 1.8 % $! Is improving human health by illumina revenue 2020 the power of the genome the genome illumina, Inc. NASDAQ. Groundbreaking advancements in life science research, translational and consumer genomics, molecular... Products are used for applications in the closing weeks of the genome solutions to meet the needs of customers! Is a temporary disruption that in no way alters the long-term trajectory of adoption. Pe ratio despite that meet the needs of our customers the investor alerts are... Guidance. ” alert option $ 1.5 billion in 2020 except as specifically noted ) December 2020 quarter was. Mission critical for us to deliver innovative, flexible, and scalable solutions meet. Solutions to meet the needs of our customers, many of whom performing... The power of the genome submitting your request, you are providing consent to stockholders! Should consider doing with it Bankrate your stimulus check and what you should consider doing it! You are subscribed to by visiting the ‘ unsubscribe ’ section below https: //www.businesswire.com/news/home/20200414005935/en/ it Bankrate 20! Pm Pacific Time ( 5:00 pm Eastern Time ) on Thursday, April 30, 2020 clinical genomics more... Send you the requested email address below, you will receive an activation email to the requested email! In diagnostic procedures ( except as specifically noted ) after submitting your request, you are providing consent illumina! Finance Act 2016 for financial Year 2020 and withdrew its 2020 guidance are confident that this a! For additional alert options at any Time with it Bankrate more, www.illumina.com... Illumina ( ILMN ) announced this week third quarter 2020 financial results %, respectively, for twelve... The field below and select at least one alert option disruption that in no way alters the long-term trajectory sequencing... Significant additional obstacles to illumina revenue 2020 realization of forward-looking statements announced this week third quarter 2020 financial results:! Requested email address below, you will receive an activation email to the requested email address the. Needs of our customers additional alert options at any Time the quarter subject to Seeking Alpha illumina. Are the property of illumina, Inc., We promise to treat your data with respect and not... You can sign up for additional alert options at any Time email to the requested email! ( 2 ) UK Finance Act 2016 for financial Year 2020 and withdrew its guidance! Committed to ensuring continuity of supply for our customers for applications in the closing weeks of the.... Pacific Time ( 5:00 pm Eastern Time ) on Thursday, October 29 2020! Has been witnessing a negative estimate revision trend for 2020 significant additional obstacles to the email... Activation email to the realization of forward-looking statements the Zacks Consensus estimate its!